Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
1(10%)
Results Posted
14%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_3
3
30%
Ph not_applicable
7
70%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
3(30.0%)
N/ANon-phased studies
7(70.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(7)
Terminated(1)
Other(1)

Detailed Status

Completed7
Terminated1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
87.5%
Most Advanced
Phase 3

Trials by Phase

Phase 33 (30.0%)
N/A7 (70.0%)

Trials by Status

terminated110%
unknown110%
active_not_recruiting110%
completed770%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10